David J Mazzo - Net Worth and Insider Trading

David J Mazzo Net Worth

The estimated net worth of David J Mazzo is at least $5,484 dollars as of 2024-05-24. David J Mazzo is the CEO of Lisata Therapeutics Inc and owns about 1,730 shares of Lisata Therapeutics Inc (LSTA) stock worth over $5,484. Details can be seen in David J Mazzo's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David J Mazzo has not made any transactions after 2015-08-17 and currently still holds the listed stock(s).

Transaction Summary of David J Mazzo

To

David J Mazzo Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David J Mazzo owns 5 companies in total, including Seneca Biopharma Inc (SNCA) , EyePoint Pharmaceuticals Inc (EYPT) , and Lisata Therapeutics Inc (LSTA) among others .

Click here to see the complete history of David J Mazzo’s form 4 insider trades.

Insider Ownership Summary of David J Mazzo

Ticker Comapny Transaction Date Type of Owner
SNCA Seneca Biopharma Inc 2020-04-03 director
EYPT EyePoint Pharmaceuticals Inc 2015-12-03 director
LSTA Lisata Therapeutics Inc 2018-06-20 director & Chief Executive Officer
2014-01-01 director & Chief Executive Officer
2019-06-17 director

David J Mazzo Latest Holdings Summary

David J Mazzo currently owns a total of 1 stock. David J Mazzo owns 1,730 shares of Lisata Therapeutics Inc (LSTA) as of August 17, 2015, with a value of $5,484.

Latest Holdings of David J Mazzo

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
LSTA Lisata Therapeutics Inc 2015-08-17 1,730 3.17 5,484

Holding Weightings of David J Mazzo


David J Mazzo Form 4 Trading Tracker

According to the SEC Form 4 filings, David J Mazzo has made a total of 0 transactions in Lisata Therapeutics Inc (LSTA) over the past 5 years. The most-recent trade in Lisata Therapeutics Inc is the acquisition of 133 shares on August 17, 2015, which cost David J Mazzo around $28,000.

Insider Trading History of David J Mazzo

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David J Mazzo Trading Performance

GuruFocus tracks the stock performance after each of David J Mazzo's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David J Mazzo is -16.43%. GuruFocus also compares David J Mazzo's trading performance to market benchmark return within the same time period. The performance of stocks bought by David J Mazzo within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how David J Mazzo's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of David J Mazzo

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 30.71
Relative Return to S&P 500(%) 36.05

David J Mazzo Ownership Network

Ownership Network List of David J Mazzo

No Data

Ownership Network Relation of David J Mazzo


David J Mazzo Owned Company Details

What does Seneca Biopharma Inc do?

Who are the key executives at Seneca Biopharma Inc?

David J Mazzo is the director of Seneca Biopharma Inc. Other key executives at Seneca Biopharma Inc include director & Executive Chairman Kenneth C Carter , director & Chief Executive Officer Richard J Daly , and Chief Financial Officer Lloyd Jones Jonathan Brian .

Seneca Biopharma Inc (SNCA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Seneca Biopharma Inc (SNCA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Seneca Biopharma Inc (SNCA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Seneca Biopharma Inc (SNCA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Seneca Biopharma Inc Insider Transactions

No Available Data

David J Mazzo Mailing Address

Above is the net worth, insider trading, and ownership report for David J Mazzo. You might contact David J Mazzo via mailing address: 110 Allen Road, 2nd Floor, Basking Ridge Nj 07920.

Discussions on David J Mazzo

No discussions yet.